Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RYZB

RayzeBio (RYZB) Stock Price, News & Analysis

RayzeBio logo

About RayzeBio Stock (NASDAQ:RYZB)

Key Stats

Today's Range
$62.49
$62.49
50-Day Range
$62.27
$62.49
52-Week Range
$17.95
$62.51
Volume
N/A
Average Volume
553,592 shs
Market Capitalization
$3.74 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RYZB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RayzeBio and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RYZB Stock News Headlines

Robinhood warning
A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fastest pace in history. CNBC calls it "the largest wealth creation spree in history." Yet 1 in 3 Americans now fear their financial situation is deteriorating. There's only one way to survive, says the man who predicted 2008 and 2020, but sadly it's already too late for many.tc pixel
Getting In on This "Macro-Trend"
Andreas Halvorsen's Firm Sells Out of RayzeBio Inc
RYZB Aug 2024 35.000 put
RYZB May 2024 55.000 put
See More Headlines

RYZB Stock Analysis - Frequently Asked Questions

RayzeBio (RYZB) raised $311 million in an initial public offering (IPO) on Friday, September 15th 2023. The company issued 17,277,600 shares at a price of $18.00 per share.

Based on aggregate information from My MarketBeat watchlists, some other companies that RayzeBio investors own include Apogee Therapeutics (APGE), Broadcom (AVGO), Citigroup (C), Citizens Financial Group (CFG), Cisco Systems (CSCO), Fifth Third Bancorp (FITB) and Intel (INTC).

Company Calendar

Today
10/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:RYZB
CIK
1825367
Fax
N/A
Employees
88
Year Founded
2020

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
31.85
Quick Ratio
31.85

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
59,920,000
Free Float
N/A
Market Cap
$3.74 billion
Optionable
Optionable
Beta
N/A

Social Links

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:RYZB) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners